National antimicrobial stewardship and fluoroquinolone-resistant Clostridium difficile in China

被引：5
|
作者：
Xiao, Meng [1 ]
Cheng, Jing-Wei [1 ,2 ]
Kudinha, Timothy [3 ]
Kong, Fanrong [4 ]
Xu, Ying-Chun [1 ,2 ]
机构：
[1] Beijing Union Med Coll Hosp, Dept Clin Lab, Shuaifuyuan St 1, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Fac Clin Lab Diagnost, Beijing, Peoples R China
[3] Charles Sturt Univ, Sch Biomed Sci, Orange, NSW, Australia
[4] Univ Sydney, Ctr Infect Dis & Microbiol Lab Serv, ICPMR Pathol West, Westmead Hosp, Westmead, NSW, Australia
来源：
INFECTION AND DRUG RESISTANCE | 2017年 / 10卷
关键词：
INFECTION;
D O I：
10.2147/IDR.S149293
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
In a recent report, Dingle et al showed that national intervention programs aimed at judicious antimicrobial usage, especially restrictions to fluoroquinolones, contributed to a significant decrease in Clostridium difficile infection (CDI) in England.1 This is considered an outstanding achievement in combating antimicrobial resistance worldwide. © 2017 Xiao et al.
引用
收藏
页码：329 / 331
页数：3
相关论文
共 50 条
  • [1] Fluoroquinolone restriction to control fluoroquinolone-resistant Clostridium difficile
    Donskey, Curtis J.
    LANCET INFECTIOUS DISEASES, 2017, 17 (04): : 353 - 354
  • [2] gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027
    Drudy, Denise
    Kyne, Lorraine
    O'Mahony, Rebecca
    Fanning, Seamus
    EMERGING INFECTIOUS DISEASES, 2007, 13 (03) : 504 - 505
  • [3] Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile
    Pawlowski, S. W.
    Archbald-Pannone, L.
    Carman, R. J.
    Alcantara-Warren, C.
    Lyerly, D.
    Genheimer, C. W.
    Gerding, D. N.
    Guerrant, R. L.
    JOURNAL OF HOSPITAL INFECTION, 2009, 73 (02) : 185 - 187
  • [4] The Antimicrobial Stewardship Approach to Combating Clostridium Difficile
    Wenzler, Eric
    Mulugeta, Surafel G.
    Danziger, Larry H.
    ANTIBIOTICS-BASEL, 2015, 4 (02): : 198 - 215
  • [5] Emergence and control of fluoroquinolone-resistant, toxin a-negative, toxin B-Positive Clostridium difficile
    Drudy, Denise
    Harnedy, Norma
    Fanning, Seamus
    Hannan, Margaret
    Kyne, Lorraine
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2007, 28 (08): : 932 - 940
  • [6] Antimicrobial activity of sitafloxacin against fluoroquinolone-resistant Neisseria gonorrhoeae
    Hamasuna, R.
    Sho, T.
    Matsumoto, M.
    Matsumoto, T.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S71 - S71
  • [7] The Intersection Between Colonization Resistance, Antimicrobial Stewardship, and Clostridium difficile
    Rossana Rosa
    Curtis J. Donskey
    L. Silvia Munoz-Price
    Current Infectious Disease Reports, 2018, 20
  • [8] Effect of an antimicrobial stewardship bundle for patients with Clostridium difficile infection
    Brumley, Paul E.
    Malani, Anurag N.
    Kabara, Jared J.
    Pisani, Jennifer
    Collins, Curtis D.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (03) : 836 - 840
  • [9] The Intersection Between Colonization Resistance, Antimicrobial Stewardship, and Clostridium difficile
    Rosa, Rossana
    Donskey, Curtis J.
    Munoz-Price, L. Silvia
    CURRENT INFECTIOUS DISEASE REPORTS, 2018, 20 (08)
  • [10] Fluoroquinolone-resistant Salmonella Paratyphi A
    Adachi, T
    Sagara, H
    Hirose, K
    Watanabe, H
    EMERGING INFECTIOUS DISEASES, 2005, 11 (01) : 172 - 174
12345